성운파마코피아의 포트폴리오를 소개합니다
| Description | |
| Product Name | Remdesivir |
| Synonym | 2-ethylbutyl
(2S)-2-[[[(2R,3S,4R,5R)-5-(4-aminopyrrolo[2,1- f][1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxyoxolan-2-yl]methoxy- phenoxyphosphoryl]amino]propanoate |
| Product Information | |
| Cas Registration No. | 1809249-37-3 |
| Chemical Formula | C27H35N6O8P |
| Molecule Weight | 602.6 |
| HS Code | |
| Application | old under the brand name Veklury, is a broad-spectrum antiviral medication developed by the biopharmaceutical company Gilead Sciences.[10] It is administered via injection into a vein. During the 2020 COVID-19 pandemic, remdesivir was approved or authorized for emergency use to treat COVID‑19 |
| Characteristics | |
| Quality Specification | |
| Appearance | White to off white Powder |
| Dose Form | Injectable Grade |
| Specification | USP |
| Storage / Packing Information | |
| Storage | 1-30℃ |
| Packing Unit | 100G / 500G / 1KG / 25KG / 100KG |
| Custom Information | |
| GMP | GMP, PIC/S |
| DMF | DMF in CTD |
| Development | Commercialized |